0001615774-18-000196.txt : 20180108 0001615774-18-000196.hdr.sgml : 20180108 20180108193450 ACCESSION NUMBER: 0001615774-18-000196 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180104 FILED AS OF DATE: 20180108 DATE AS OF CHANGE: 20180108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McGuire Jonathan Will CENTRAL INDEX KEY: 0001345539 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36747 FILM NUMBER: 18517593 MAIL ADDRESS: STREET 1: 96 TALAMINE COURT CITY: COLORADO SPRINGS STATE: CO ZIP: 80907 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SECOND SIGHT MEDICAL PRODUCTS INC CENTRAL INDEX KEY: 0001266806 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3 CITY: SYLMAR STATE: CA ZIP: 91342 BUSINESS PHONE: 818-833-5000 MAIL ADDRESS: STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3 CITY: SYLMAR STATE: CA ZIP: 91342 4 1 s108662_form4.xml 4 X0306 4 2018-01-04 0 0001266806 SECOND SIGHT MEDICAL PRODUCTS INC EYES 0001345539 McGuire Jonathan Will 12744 SAN FERNANDO ROAD SUITE 400 SYLMAR CA 91342 1 1 0 0 Chief Executive Officer Common Stock 81339 D Non-Qualified Stock Option (right to buy) 2.06 2018-01-04 4 A 0 450000 D 2019-01-04 2028-01-04 Common Stock 450000 450000 D Warrant to Purchase Common Stock 1.47 2017-03-14 2022-03-14 Common Stock 6794 6794 D Non-Qualified Stock Option (right to buy) 1.97 2018-01-03 2027-01-03 Common Stock 571330 571330 D Non-Qualified Stock Option (right to buy) 4.1 2017-01-21 2026-01-21 Common Stock 21290 21290 D Non-Qualified Stock Option (right to buy) 12.43 2016-08-17 2025-08-17 Common Stock 420000 420000 D Restricted Stock Unit (RSU) 2016-08-17 2019-08-17 Common Stock 190000 83125 D The shares subject to this option shall vest and become exercisable at a rate of 25% of the total number of shares on the one-year anniversary of January 4, 2018 (the "Vesting Commencement Date") and 6.25% of the total number of shares shall vest each quarterly anniversary of the Vesting Commencement Date thereafter, for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date. Options and RSUs vest over a 4 year term, with 25% vesting on the Date Exercisable as set forth in this Form 4 and thereafter vesting in 12 equal quarterly installments of 6.25%. Not Applicable /s/ Jonathan Will McGuire 2018-01-08